BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 23, 2026
Home
»
Authors
» Nuala Moran
Nuala Moran
Articles
ARTICLES
Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms
April 4, 2001
By
Nuala Moran
Oxford Gene, Affymetrix Settle Microarray Patent Litigation
April 4, 2001
By
Nuala Moran
Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms
April 4, 2001
By
Nuala Moran
Oxford Gene, Affymetrix Settle Microarray Patent Litigation
April 4, 2001
By
Nuala Moran
Proteome Sciences Establishing Proteomics Facility, Collaboration
March 28, 2001
By
Nuala Moran
Inpharmatica Gains Partner, Investment In Genentech Deal
March 28, 2001
By
Nuala Moran
Proteome Sciences Establishing Proteomics Facility, Collaboration
March 28, 2001
By
Nuala Moran
Inpharmatica Gains Partner, Investment In Genentech Deal
March 28, 2001
By
Nuala Moran
PPL Braves Tough Market In Public Attempt To Raise £45M
March 21, 2001
By
Nuala Moran
Matrix Secures £2M In First Round For Drugs, Diagnostics
March 21, 2001
By
Nuala Moran
View All Articles by Nuala Moran